CABALETTA BIO Trademark

Trademark Overview

On Tuesday, July 3, 2018, a trademark application was filed for CABALETTA BIO with the United States Patent and Trademark Office. The USPTO has given the CABALETTA BIO trademark a serial number of 88024185. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2022. This trademark is owned by Tycho Therapeutics, Inc.. The CABALETTA BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-infectives, psychotropics, pharmaceutical skin lotions, plant extracts for pharmaceutical purposes, starch for pharmaceutical purposes, thymol for pharmaceutical purposes, yeast for pharmaceutical purposes; pharmaceutical preparations, namely, anticoagulants, antidepressants, antivirals, appetite suppressants, pharmaceutical preparations for the for the treatment and prevention of autoimmune and alloimmune diseases; drug therapies, namely, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
cabaletta bio

General Information

Serial Number88024185
Word MarkCABALETTA BIO
Filing DateTuesday, July 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2018

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-infectives, psychotropics, pharmaceutical skin lotions, plant extracts for pharmaceutical purposes, starch for pharmaceutical purposes, thymol for pharmaceutical purposes, yeast for pharmaceutical purposes; pharmaceutical preparations, namely, anticoagulants, antidepressants, antivirals, appetite suppressants, pharmaceutical preparations for the for the treatment and prevention of autoimmune and alloimmune diseases; drug therapies, namely, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCABALETTA BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameCABALETTA BIO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressVILLANOVA, PA 19085
Party NameTycho Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVillanova, PA 19085

Trademark Events

Event DateEvent Description
Monday, March 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 4, 2021SOU EXTENSION 5 GRANTED
Tuesday, July 20, 2021SOU EXTENSION 5 FILED
Tuesday, July 20, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021SOU EXTENSION 4 GRANTED
Thursday, January 28, 2021SOU EXTENSION 4 FILED
Thursday, January 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 3 GRANTED
Tuesday, July 28, 2020SOU EXTENSION 3 FILED
Tuesday, July 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020CORRECTED NOA E-MAILED
Tuesday, March 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2020SOU EXTENSION 2 GRANTED
Wednesday, January 29, 2020SOU EXTENSION 2 FILED
Monday, March 2, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, January 29, 2020DIVISIONAL REQUEST RECEIVED
Monday, March 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 29, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 29, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, January 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 10, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019SOU EXTENSION 1 GRANTED
Wednesday, June 19, 2019SOU EXTENSION 1 FILED
Wednesday, June 19, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, January 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018ASSIGNED TO EXAMINER
Wednesday, October 17, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 6, 2018NEW APPLICATION ENTERED

Related Keywords

cabaletta pharmaceutical purposes namely preparations diseases treatment disorders therapies alloimmune autoimmune